BAXTER LOOKS TO LATIN AMERICA

12 June 1994

Baxter International has said that it expects to more than double its business in Latin America by 1997, with sales projected to reach around $500 million. Its 1993 sales in the region were just over $241 million.

Baxter employs around 1,700 people in Central and South America and the Caribbean islands. Over 1,100 of Baxter's staff work in its four manufacturing plants, two of which are located in Sao Paulo in Brazil. One plant manufactures dialysis and intravenous solutions; the other produces blood oxygenators and heart valves. There are other plants in Colombia and Mexico. In Cali, Colombia, Baxter manufactures dialysis and intravenous solutions, and administration sets. In Cuernavaca, Mexico, the plant produces dialysis and intravenous solutions, plus Fenwal blood bags.

Baxter is the market leader in Latin America in peritoneal-dialysis solutions and supplies, blood bags and, in some countries, IV solutions. Renal products make up over 40% of sales in the region, while blood bags and blood-component products and cardiovascular products each make up under 10%. Baxter's international hospital business, which focuses on IV solutions, sets, gloves, surgical instruments and other products, makes up 40% of sales in the region.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight